No label defined (Q58648371)

From Wikidata

Jump to navigation Jump to search

Scientific article

Language	Label	Description	Also known as
English	No label defined	Scientific article

Statements

scholarly article

0 references

author name string

Lyse A Norian

1

0 references

Tamara A Kucaba

2

0 references

James K Earel

3

0 references

Tina Knutson

4

0 references

Rebecca L Vanoosten

5

0 references

Thomas S Griffith

6

0 references

language of work or name

0 references

publication date

2009

0 references

Journal of oncology

0 references

2009

0 references

408038

0 references

copyright license

Creative Commons Attribution 3.0 Unported

1 January 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Targeting death receptors in cancer with Apo2L/TRAIL.

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

The receptor for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Mechanisms of apoptosis

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Apoptosome dysfunction in human cancer

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Caspase-9 regulation: an update

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL).

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Apo2L/TRAIL and its death and decoy receptors

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Chronic lymphocytic leukaemia: the nature of the leukaemic cell

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Anticancer activities of histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Histone deacetylase inhibitors in cancer therapy

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Translating the Histone Code

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Histone deacetylases and cancer: causes and therapies

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Histone deacetylase inhibitors enhance Ad5-TRAIL killing of TRAIL-resistant prostate tumor cells through increased caspase-2 activity

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Enhancement of Ad5-TRAIL cytotoxicity against renal cell carcinoma with histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Modulation of TRAIL-induced apoptosis by HDAC inhibitors

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Inhibition of Histone Deacetylase Class I but not Class II Is Critical for the Sensitization of Leukemic Cells to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Histone deacetylase inhibitors modulate the sensitivity of tumor necrosis factor-related apoptosis-inducing ligand-resistant bladder tumor cells

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Inhibition of the NF-kappaB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Histone deacetylase inhibitors modulate renal cell carcinoma sensitivity to TRAIL/Apo-2L-induced apoptosis by enhancing TRAIL-R2 expression

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Simplified apoptotic cascades

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

The pathophysiology of mitochondrial cell death

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F408038

21 January 2018

Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696620

30 November 2018

Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696620

30 November 2018

TRAIL: a molecule with multiple receptors and control mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547714

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547714

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective inhibition of PED protein expression sensitizes B-cell chronic lymphocytic leukaemia cells to TRAIL-induced apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19547714

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1155/2009/408038

0 references

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58648371&oldid=1801950287"